{"id":52916,"date":"2026-01-05T22:38:41","date_gmt":"2026-01-05T14:38:41","guid":{"rendered":"https:\/\/flcube.com\/?p=52916"},"modified":"2026-01-05T22:38:43","modified_gmt":"2026-01-05T14:38:43","slug":"kangtai-biological-co-founds-beijing-laboratory-to-advance-synthetic-immunology-and-vaccine-manufacturing","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=52916","title":{"rendered":"Kangtai Biological Co\u2011founds Beijing Laboratory to Advance Synthetic Immunology and Vaccine Manufacturing"},"content":{"rendered":"\n

Shenzhen Kangtai Biological Products Co., Ltd.<\/strong> (SHE: 300601<\/a>) announced that its wholly\u2011owned subsidiary Minhai Biotechnology<\/strong> has co\u2011founded the Beijing Key Laboratory of Synthetic Immunology and Vaccine Intelligent Manufacturing<\/strong> with the Institute of Microbiology of the Chinese Academy of Sciences (CAS)<\/strong>, Xinzhi Bio<\/strong>, and Liaoning Cheng Da Biotechnology<\/strong>. The laboratory aims to achieve breakthroughs in antigen design, adjuvant development, and intelligent vaccine production<\/strong> to establish a world\u2011leading rapid response system.<\/p>\n\n\n\n

Laboratory Overview<\/h2>\n\n\n\n
Item<\/th>Detail<\/th><\/tr><\/thead>
Name<\/strong><\/td>Beijing Key Laboratory of Synthetic Immunology and Vaccine Intelligent Manufacturing<\/td><\/tr>
Host<\/strong><\/td>Institute of Microbiology, Chinese Academy of Sciences (CAS)<\/td><\/tr>
Co\u2011Founders<\/strong><\/td>Minhai Biotechnology (Kangtai Biological 300601.SZ subsidiary), Xinzhi Bio, Liaoning Cheng Da Biotechnology<\/td><\/tr>
Strategic Focus<\/strong><\/td>Synthetic immunology and intelligent vaccine manufacturing<\/td><\/tr>
Core Objectives<\/strong><\/td>Breakthroughs in antigen design, adjuvants, delivery systems, quality control; overcome multivalent vaccine bottlenecks<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Core Research Directions<\/h2>\n\n\n\n

1. AI\u2011Assisted Precision Immunogen Design<\/strong><\/p>\n\n\n\n